These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36018128)

  • 21. Prevalence of Incidentally Detected Signs of Intracranial Hypertension on Magnetic Resonance Imaging and Their Association With Papilledema.
    Chen BS; Meyer BI; Saindane AM; Bruce BB; Newman NJ; Biousse V
    JAMA Neurol; 2021 Jun; 78(6):718-725. PubMed ID: 33871552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension.
    Padhye LV; Van Stavern GP; Sharma A; Viets R; Huecker JB; Gordon MO
    J Neurol Sci; 2013 Sep; 332(1-2):80-5. PubMed ID: 23850064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic Endonasal Optic Nerve Decompression in Idiopathic Intracranial Hypertension: When to Implement Optic Nerve Sheath Fenestration.
    Ahmedov ML; Tahmazoglu B; Aydin S; Kartum TA; Mergen B; Yildirim SR; Kemerdere R; Tanriover N
    Oper Neurosurg (Hagerstown); 2023 Oct; 25(4):315-323. PubMed ID: 37345928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of ultrasonographic optic nerve sheath diameter in the diagnosis and follow-up of papilledema and its correlation with Frisén's severity grading.
    Raghunandan N; Joseph M; Nithyanandam S; Karat S
    Indian J Ophthalmol; 2019 Aug; 67(8):1310-1313. PubMed ID: 31332116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and imaging features of idiopathic intracranial hypertension.
    Wang Z; Yang J; Liao X; Xie N; Luo M; Tian Y; Yao L; Hu Y; Yi F; Zhou Y; Zhou L; Xu H; Sun Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Nov; 46(11):1241-1250. PubMed ID: 34911859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension.
    Skau M; Yri H; Sander B; Gerds TA; Milea D; Jensen R
    Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):567-74. PubMed ID: 22592348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Vienna idiopathic intracranial hypertension database-An Austrian registry.
    Pruckner P; Mitsch C; Macher S; Krajnc N; Marik W; Novak K; Wöber C; Pemp B; Bsteh G
    Wien Klin Wochenschr; 2024 Jan; 136(1-2):32-39. PubMed ID: 37650963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients.
    Goodwin CR; Elder BD; Ward A; Orkoulas-Razis D; Kosztowski TA; Hoffberger J; Moghekar A; Radvany M; Rigamonti D
    Clin Neurol Neurosurg; 2014 Dec; 127():75-8. PubMed ID: 25459247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of tumor necrosis factor-alpha in the pathophysiology of idiopathic intracranial hypertension.
    Fahmy EM; Rashed LA; Mostafa RH; Ismail RS
    Acta Neurol Scand; 2021 Nov; 144(5):509-516. PubMed ID: 34131899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased intracranial pressure in spontaneous CSF leak patients is not associated with papilledema.
    Aaron G; Doyle J; Vaphiades MS; Riley KO; Woodworth BA
    Otolaryngol Head Neck Surg; 2014 Dec; 151(6):1061-6. PubMed ID: 25248848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sonographic assessment of the optic nerve and the central retinal artery in idiopathic intracranial hypertension.
    Jeub M; Schlapakow E; Ratz M; Kindler C; Schievelkamp AH; Wabbels B; Kornblum C
    J Clin Neurosci; 2020 Feb; 72():292-297. PubMed ID: 31540860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients.
    Kabatas N; Eren Y; Nalcacioglu P; Caliskan S; Bicer T; Comoglu SS; Gurdal C
    Int Ophthalmol; 2021 Apr; 41(4):1467-1477. PubMed ID: 33481155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic intracranial hypertension in children: Diagnostic and management approach.
    Albakr A; Hamad MH; Alwadei AH; Bashiri FA; Hassan HH; Idris H; Hassan S; Muayqil T; Altweijri I; Salih MA
    Sudan J Paediatr; 2016; 16(2):67-76. PubMed ID: 28096561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sonographic assessment of optic nerve and ophthalmic vessels in patients with idiopathic intracranial hypertension.
    Ebraheim AM; Mourad HS; Kishk NA; Badr Eldin N; Saad AA
    Neurol Res; 2018 Sep; 40(9):728-735. PubMed ID: 29799769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound evaluation of internal jugular valve incompetence (IJVI) in Egyptian patients with idiopathic intracranial hypertension (IIH).
    Fahmy IM; Abokrysha NT; Ahmed SM; El-Shebawy HM
    J Neurol Sci; 2016 Jan; 360():18-22. PubMed ID: 26723965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Characteristics of Idiopathic Intracranial Hypertension in Patients Over 50 Years of Age: A multicenter clinical cohort study.
    Downie PA; Chen JJ; Bhatti MT; Melson AT; Van Stavern GP; McClelland CM; Lindgren BR; Sharieff JA; Lee MS
    Am J Ophthalmol; 2021 Apr; 224():96-101. PubMed ID: 33253662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the optic nerve stiffness and optic nerve sheath diameter in idiopathic intracranial hypertension patients after the resolution of papilledema.
    Kaya FS; Bayram E; İnci E
    Neurol Sci; 2021 Dec; 42(12):5165-5170. PubMed ID: 33788047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension.
    Bidot S; Clough L; Saindane AM; Newman NJ; Biousse V; Bruce BB
    J Neuroophthalmol; 2016 Jun; 36(2):120-5. PubMed ID: 26580295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of Magnetic Resonance Imaging Features for Improving the Diagnosis of Idiopathic Intracranial Hypertension Without Papilledema.
    Mallery RM; Rehmani OF; Woo JH; Chen YJ; Reddi S; Salzman KL; Pinho MC; Ledbetter L; Tamhankar MA; Shindler KS; Digre KB; Friedman DI; Liu GT
    J Neuroophthalmol; 2019 Sep; 39(3):299-307. PubMed ID: 30829949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normative body mass-adjusted reference ranges of magnetic resonance imaging signs commonly used in diagnosing idiopathic intracranial hypertension in a healthy standard population.
    Kobrow R; Gross S; Fleischmann R; Baldauf J; Langner S; Strauss S
    Sci Rep; 2024 Feb; 14(1):4492. PubMed ID: 38396059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.